Trial Profile
A Phase 1, Open-label, Randomized, Crossover Design Clinical Trial in Healthy Normal Volunteers to Evaluate Insulin Exposure and Effect Following Inhalation of Technosphere(R) Insulin Inhalation Powder at Multiple Doses Using the Gen2C Inhaler.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Sep 2016
Price :
$35
*
At a glance
- Drugs Insulin (Primary) ; Insulin
- Indications Diabetes mellitus
- Focus Pharmacokinetics
- Sponsors MannKind Corporation
- 25 Jun 2013 Results presented at the 73rd Annual Scientific Sessions of the American Diabetes Association.
- 01 Jul 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 May 2012 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.